Malignant pleural mesothelioma (MPM) is a rare tumor
|
|
- Oswald Eustace Crawford
- 5 years ago
- Views:
Transcription
1 Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping Luka Brcic, MD, PhD; Gregor Vlacic, MD; Franz Quehenberger, PhD; Izidor Kern, MD Context. Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis. Several studies have analyzed potential prognostic markers, but histologic type remains the single most important prognostic factor. Histologic subtypes of epithelioid MPM seem to have prognostic and therapeutic implications. Interobserver agreement in histologic pattern classification should be high. Objective. To assess interobserver and intraobserver reproducibility in histologic differentiation between the main types of MPMs, and in further subtyping of epithelioid-type mesothelioma. Design. One representative hematoxylin-eosin stained slide was selected from the archive for each of 200 patients with MPM. They were reviewed independently by 3 pathologists and classified according to the current World Health Organization classification of pleural tumors. After the first round of evaluations, a consensus meeting was organized where problems were addressed and representative images for each histologic category were selected. Two months later, cases were reevaluated by all 3 pathologists. Results. After the first round, overall interobserver agreement for histologic subtyping of mesothelioma was fair (j, 0.36). The agreement was increased to substantial (j, 0.63) in the second round. Improvement was found in interobserver agreement for all types of MPM and for most epithelioid subtypes. Conclusions. Moderate to substantial agreement in histologic typing and subtyping of MPM can be achieved. However, training with additional clarification of diagnostic criteria, their strict application, and help from consensus-based illustrative images is needed. (Arch Pathol Lab Med. 2018;142: ; doi: / arpa oa) Malignant pleural mesothelioma (MPM) is a rare tumor but is also the most common primary malignant tumor of the pleura and has a dismal prognosis. Classical cases are caused by asbestos exposure and present after a long latency period. The incidence of MPM in the United States is decreasing owing to earlier asbestos use control. 1 However, in many other developed and developing countries, it is expected to reach a peak in the next 5 to 10 years. 2 Although there are occasional reports of patients living more than 5 years after the first diagnosis, most commonly, patients are diagnosed in an advanced stage and have a median survival of up to 13 months regardless of treatment modalities. 3 5 Previous studies 6,7 have analyzed different clinical, radiologic, and pathologic variables as prognostic factors. Accepted for publication September 6, Published as an Early Online Release March 6, From the Institute of Pathology (Dr Brcic) and the Institute for Medical Informatics, Statistics and Documentation (Dr Quehenberger), Medical University of Graz, Graz, Austria; and Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia (Drs Vlacic and Kern). The authors have no relevant financial interest in the products or companies described in this article. Presented in part as an oral presentation at the 13th International Conference of the International Mesothelioma Interest Group (imig 2016); May 1 4, 2016; Birmingham, United Kingdom. Corresponding author: Luka Brcic, MD, PhD, Institute of Pathology, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria ( luka.brcic@medunigraz.at). Histologic type is still the most important single prognostic factor. The epithelioid type of MPM is associated with significantly better survival than the sarcomatoid and biphasic types. 8,9 Even more, histologic subtyping is currently used to make treatment decisions. 10 According to the latest World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart, 11 the epithelioid type is very heterogeneous. It presents with different histologic patterns. Among these, the most common are solid, tubulopapillary, and trabecular, followed by micropapillary, adenomatoid, clear cell, transitional, deciduoid, and pleomorphic. 11 The prognostic significance of different histologic patterns of epithelioid mesotheliomas has been analyzed in a few studies, which suggest poorer survival for individuals with the pleomorphic pattern In contrast, the myxoid/microcystic pattern was shown to be a favorable prognostic marker. 15 Furthermore, Kadota et al 13 have reported better prognosis for individuals with mesotheliomas presenting with trabecular or tubulopapillary patterns than for those with other epithelioid mesothelioma patterns. Proper histologic subtyping of epithelioid MPM may be a potentially useful tool for prognostic stratification of patients. It is therefore essential to have uniform diagnostic criteria and terminology, as well as good interobserver reproducibility among pathologists. However, although there are few studies regarding interobserver reproducibility in the diagnosis of MPM, mainly focused on immunohistologic reproducibility, there is only 1 Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al 747
2 published article analyzing the reproducibility of histologic subtyping in epithelioid MPM. 12 The purpose of this study was to assess interobserver and intraobserver reproducibility in the histologic differentiation between the main types of MPMs, and in further subtyping of epithelioid MPM. The impact of a consensus meeting, during which a representative set of slides was agreed upon, was evaluated. MATERIALS AND METHODS Mesothelioma Samples We identified 200 consecutive samples from patients diagnosed with MPM in the archives of the Institute of Pathology University of Zagreb School of Medicine, Zagreb, Croatia (100) and the Cytology and Pathology Laboratory at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia (100). Most of the patients were diagnosed by video-assisted thoracoscopic biopsies (137 of 200 patients, 68.5%), while 39 (19.5%) had pleurectomy and 24 (12%) underwent percutaneous pleural needle core biopsies. The original diagnoses of all samples were made by using at least 2 mesothelial cell markers (calretinin, cytokeratin 5/6, WT-1, D2-40, or thrombomodulin), and at least 2 negative markers (Ber-EP4, MOC31, carcinoembryonic antigen, or thyroid transcription factor-1). Only 1 representative hematoxylin-eosin (HE) stained slide from each case was selected for this study. All slides were digitized with an Aperio scanner (Leica Biosystems, Wetzlar, Germany) with an 340 objective and reviewed independently by 3 pathologists (L.B., G.V., I.K.). Two pathologists (I.K., L.B.) are specialized in pulmonary pathology and have 20 and 5 years of experience, respectively. The third pathologist (G.V.) is a young pathologist with 1 year of experience in pulmonary pathology. Whole slide images from patients with MPM were classified as epithelioid, sarcomatoid, or biphasic according to the 2015 WHO criteria for the classification of pleural tumors. 11 Epithelioid MPM cases were further subtyped according to the predominant pattern as acinar, adenomatoid (microglandular), micropapillary, solid, tubulopapillary, trabecular, pleomorphic, clear cell, deciduoid, signet ring cell, or small cell variant, as defined previously. 13,19,20 After the first round of evaluations, a consensus meeting was organized. During this meeting, diagnostic problems were addressed and slides with discordant diagnoses were jointly reviewed. Reference images (Figure 1, A through H) illustrating typical patterns for each histologic category were selected and later shared among all of the reviewers. All cases were reevaluated by all 3 pathologists after an interval of 2 months following the consensus meeting. The pathologists were allowed to synchronously review the reference images. Reproducibility of the subtyping between the first and the second round for each pathologist was assessed as well (intraobserver reproducibility). To evaluate the influence of the sample size on the reproducibility, overall interobserver agreement, after both rounds, was analyzed for the (small) group of samples obtained by percutaneous pleural needle biopsy. Statistical Analysis To evaluate the reproducibility of histopathologic mesothelioma subtyping, interobserver variability was calculated. Furthermore, the effect of the consensus meeting on the diagnoses of each individual pathologist was assessed. Cohen j was used to assess interobserver and intraobserver agreement. Values of 0.20 to 0.40, 0.41 to 0.60, 0.61 to 0.80, and greater than 0.80 were taken to reflect fair, moderate, substantial, and excellent agreement, respectively. 21 Analyses were performed with R ( accessed November 3, 2016) and the irr 0.84 package. RESULTS Assessment of overall interobserver agreement of histologic subtyping of mesothelioma during the first round of evaluation led to a j value of only 0.36 (fair agreement), with j values between each pair of pathologists equal to 0.34, 0.35, and 0.38 (Figure 2). The highest overall interobserver agreement was observed for the sarcomatoid type of MPM, followed by the epithelioid type (0.60 and 0.50, respectively). Classification of MPM as biphasic, based on the HE slides only, appeared to be very difficult, as reflected by a j value of In further subtyping epithelioid MPM, the best agreements were detected for tubulopapillary, pleomorphic, and trabecular patterns (0.54, 0.49, and 0.42, respectively) (Table). At the consensus meeting, several problems were addressed, possible solutions were discussed, and consensus was defined. As expected, since our approach included only HE-stained slides, the criteria used to identify spindle cells as malignant mesothelial cells were slightly different for each reviewer. We agreed upon strict criteria for the identification of sarcomatoid and biphasic types of MPM at the meeting. Namely, all samples with tumors consisting of spindle cells with atypia and polymorphous appearance or mesenchymal-appearing cells were to be classified as sarcomatoid. At least 10% of each, epithelioid and sarcomatoid components, were required in order to classify MPM as biphasic. However, we are aware that without additional analysis, the decision of whether a spindle-cell component represented cellular reactive stroma or a genuine sarcomatoid component is not possible. Another issue discussed was the assessment of morphologically striking pseudodominating patterns, such as micropapillary or papillary patterns. It was sometimes difficult to accurately determine the percentage of area covered by these patterns when they were present. There was a tendency to allocate higher percentages of area to these striking patterns. It was stressed at the meeting that very careful analysis of the whole slide is mandatory. Some cases with solid patterns were classified as deciduoid on the basis only of the larger amount of cytoplasm even if pronounced eosinophilia or glassy cytoplasm was not observed. Interestingly, and not at all expected, one of the largest problems was defining and classifying the trabecular pattern. By definition, this pattern consists of small cells in thin cords or single files. However, when there was a slitlike space appearing in between 2 cell lines, sometimes wider and sometimes narrower in the same analyzed area, it was difficult not to refer to this pattern as a crushed acinar pattern. It was decided to classify this pattern as trabecular only when a narrow space was present or when there was no space between the cords of cells. Other problems were noted with the acinar pattern, which is defined as a pattern with glandlike structures. Namely, it was unclear when to identify small glandlike structures as glands, and when to refer to them as microcysts. As a result, the adenomatoid pattern was sometimes difficult to define. Two months after the consensus meeting, a second evaluation round yielded a higher j value of 0.63 (substantial agreement) for overall interobserver agreement, with improved reproducibility for each pair of pathologists (j values of 0.56, 0.64, and 0.70) (Figure 3). Significant improvement in interobserver agreement was detected for all major types of MPM (Table). For epithelioid type, j values in the first and second rounds were 0.50 and 0.74, respectively. These values were similar to those for sarcomatoid type (0.60 and 0.90). Interestingly, the concordance for the biphasic group showed the strongest improvement, with j increasing from 0.28 to 0.64 (fair to 748 Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al
3 Figure 1. Representative images of selected histologic patterns. Solid (A), deciduoid (B), pleomorphic (C), micropapillary (D), acinar (E), trabecular (F), tubulopapillary (G), and signet ring cell (H) patterns are presented (hematoxylin-eosin, original magnifications 320 [A, B, C, D, E, F, and H] and 310 [G]). Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al 749
4 Interobserver Agreement According to the Histologic Types and Subtypes of Malignant Pleural Mesothelioma After the First and Second Rounds of Slide Viewing Histologic Type Histologic Subtype First-Round j Value Second-Round j Value Epithelioid Acinar Adenomatoid Deciduoid Micropapillary Trabecular Tubulopapillary Pleomorphic Rhabdoid Signet ring cell Solid Sarcomatoid Biphasic Figures 2 and 3. General interobserver reproducibility. Interobserver reproducibility between pairs of pathologists (A, B, and C) after the first (Figure 2) and second (Figure 3) rounds of slide review demonstrate an increase from fair (0.34, 0.35, and 0.38) to moderate (0.56) and substantial (0.64 and 0.70) agreement. substantial agreement). In subanalysis of histologic subtypes after the first and second rounds, consensus regarding a diagnosis of micropapillary, deciduoid, and solid patterns showed the highest improvements. For the diagnosis of acinar subtype, however, interobserver agreement remained low, with j values of 0.29 and 0.32 (fair agreement). Analysis of intraobserver reproducibility between the 2 rounds revealed moderate agreement for all pathologists (j values of 0.56, 0.56, and 0.50), with the lowest value found for the least experienced pathologist. Overall interobserver agreement for the samples obtained by percutaneous pleural needle biopsy after the first round showed j value of 0.33 (fair agreement), which was the same as for the whole study group (j, 0.36). However, after the second round, in this small group, j value of 0.56 was reached (moderate agreement), which was poorer than 0.63 (substantial agreement) found for the whole study group. DISCUSSION Although many reports have been published regarding new prognostic markers for mesothelioma, their results are still controversial and histologic classification remains the most important prognostic factor. Histologic criteria for typing and subtyping of MPM have been developed 11,19 and are applied in daily diagnostic practice. Some relatively recent studies 8,9 have shown that survival significantly differs depending on specific histologic types of mesotheliomas, notably with poorer overall survival for sarcomatoid and biphasic types than for epithelioid type. As importantly, treatment decisions today are also based on histologic subtyping. 10 To use histologic subtyping, which is fast and inexpensive, as a clinical prognostic marker, the use of welldefined criteria and high reproducibility of the diagnoses are essential. Although immunohistochemistry is reliable when assessing epithelioid types of MPM, it can be less effective when used to classify sarcomatoid and biphasic MPM. Sarcomatoid MPM is defined as a malignant tumor composed of spindle and mesenchymal-appearing tumor cells of mesothelial origin. These tumors are almost always positive for cytokeratins and often lack detectable expression of mesothelial markers. 11 Biphasic MPM requires at least 10% of sarcomatoid and epithelioid patterns for diagnosis. Because of these difficulties with immunohistochemistry in sarcomatoid MPM, it might be difficult to differentiate reactive stroma of epithelioid MPM from biphasic MPM. In mesothelial proliferations, the combination of loss of BAP1 expression and p16 deletion, as determined by fluorescence in situ hybridization, has been shown to be a reliable marker of malignancy. However, the reverse staining pattern cannot rule out mesothelioma. 22 According to Righi et al, 23 BAP1 expression might also be useful for distinguishing biphasic MPM from epithelioid MPM with reactive stroma. The problems associated with differentiating the major MPM types on HE-stained slides only were also apparent in our study. This was reflected as fair (biphasic) and moderate (sarcomatoid and epithelioid) interobserver reproducibility after the first round. After the consensus meeting, selection of representative images, and application of strict morphologic criteria, the reproducibility was improved. Interobserver reproducibility was now moderate for biphasic, substantial for epithelioid, and excellent for sarcomatoid type. During the consensus meeting, representative slides with desmoplastic stromal reaction were compared to sarcomatoid and biphasic mesotheliomas. We decided to classify atypical and pleomorphic spindle cells, especially those with high cellularity, as sarcomatoid mesothelial cells. We are aware of the fact that this might also be only reactive stroma, but the above approach was the only possible solution in our pure morphologic approach. This may 750 Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al
5 limit our study to a certain degree. However, the more important aim of this study was to assess the reproducibility of the patterns in the epithelioid type of MPM. Like adenocarcinoma of the lung, epithelioid MPM is histologically very heterogeneous. It is very often composed of more than 2 different growth patterns. As previously mentioned, there is prognostic importance in the further subtyping of epithelioid MPM ,24 This is even more important if histologic subtyping is reproducible, as it might also be correlated with radiologic, biological, and molecular/ genetic findings, similar to lung adenocarcinoma In the first round of this study, we found interobserver reproducibility of histopathologic subtyping of epithelioid malignant mesothelioma to be fair, which was lower than expected. This clearly reflects the difficulty with such diagnoses. At the consensus meeting, we carried out detailed analyses of problematic cases, discussed problems, and defined consensus. Furthermore, a set of representative images for each pattern was compiled and later used as a tool for decision support when deciding on MPM subtype. This educational effort led to appreciable improvement in the second round interobserver agreement, although after a rather short period of 2 months. Interobserver reproducibility increased appreciably, as reflected in higher j values (substantial agreement). Interestingly, the acinar pattern led to the most problems in both rounds. Based on our experience, the problem is not so much in the definition of the acinar pattern, but in the definition of the trabecular and adenomatoid patterns. When are glandlike structures to be considered microglandular structures? Should there be a slit in between the cords of cells defining the trabecular pattern? If yes, when does this slit become a glandlike structure ( crushed acinar pattern ) (Figure 4, A through C)? There are no answers to these questions in the available literature. We have demonstrated that the sample size is another limiting factor: in samples obtained by percutaneous pleural needle biopsy, overall interobserver agreement increased from fair (after the first round) to moderate agreement (after the second round), which was lower when compared to the whole study group (from fair to substantial agreement). The importance of this finding is even greater, since this difference was obtained in a rather small group of only 24 samples (which is at the same time the limiting factor of this subanalysis). Another limitation of our study may stem from the differences in the levels of experience among the pathologists. However, from the intraobserver reproducibility (comparison between the first and second round results for each pathologist), which showed moderate agreement for all, we conclude that this is not in fact a limitation. Even more, it was clearly shown that even the most experienced pathologist changed the manner in which he subtyped the slides in approximately the same number of cases as the other 2 pathologists after the consensus meeting. This also demonstrates the need for better definitions and clear criteria for specific patterns of epithelioid MPM. Earlier analogous approaches in breast carcinoma 28 and soft tissue sarcomas 29 have led to similar results. Even when experienced pathologists were questioned, histologic pattern reproducibility (in lung adenocarcinoma) proved to be problematic, but increased after education and training The German group also showed that the increase in reproducibility is different for different patterns of lung adenocarcinoma. 30 Similar findings have now been presented for MPM. To our knowlwdge, only 1 study has been Figure 4. Discrepant cases. Samples for which interobserver reproducibility was not achieved in the second round are displayed: trabecular or acinar pattern (A and B); signet ring cell, adenomatoid/ microglandular, or acinar pattern (C) (hematoxylin-eosin, original magnifications 35 [A], 320 [B], and 310 [C]). conducted regarding mesothelioma subtyping, wherein one of our authors (L.B.) participated. 12 However, the mesothelioma cohort was smaller, only 2 pathologists from a single institution participated, and intraobserver reproducibility was not addressed. CONCLUSIONS Our study demonstrated that moderate to substantial agreement in histologic typing and subtyping of MPM can be achieved. Size of the sample seems to be an important limiting factor in achieving this agreement. Furthermore, consensus-based illustrative images improve learning and help in achieving higher consensus in the classification of MPM. In spite of all this, even among experienced Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al 751
6 pulmonary pathologists excellent agreement was not achieved for most of the histologic types/subtypes. This clearly points to the need for additional clarification of diagnostic criteria at least for some patterns, which would improve diagnostic reproducibility. References 1. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. SEER cancer statistics review , mesothelioma. mesothelioma.pdf. Accessed December 28, Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353(15): Beebe-Dimmer JL, Fryzek JP, Yee CL, et al. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol. 2016;8: Bille A, Belcher E, Raubenheimer H, et al. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy s and St Thomas hospitals. Gen Thorac Cardiovasc Surg. 2012;60(5): Gill RR, Richards WG, Yeap BY, et al. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol. 2012;198(2): Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Re OD. The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev. 2015;41(6): Hoda MA, Dong Y, Rozsas A, et al. Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma a multi-institutional study. Eur J Cancer. 2016;63: Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7(11): Meyerhoff RR, Yang CF, Speicher PJ, et al. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res. 2015;196(1): NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelinest). Malignant Pleural Mesothelioma, version July 7, nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed July 9, Galateau-Salle F, Churg A, Roggli V, et al. Diffuse malignant mesothelioma. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, eds. WHO Classifiction of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: International Agency for Research on Cancer; 2015: World Health Organization Clssification of Tumours; vol Brčić L, Jakopović M, Brčić I, et al. Reproducibility of histological subtyping of malignant pleural mesothelioma. Virchows Arch. 2014;465(6): Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol. 2011;6(5): Ordóñez NG. Pleomorphic mesothelioma: report of 10 cases. Mod Pathol. 2012;25(7): Alchami FS, Attanoos RL, Bamber AR. Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma. J Clin Pathol. 2017;70(2): Betta PG, Andrion A, Donna A, et al. Malignant mesothelioma of the pleura: the reproducibility of the immunohistological diagnosis. Pathol Res Pract. 1997;193(11 12): Andrion A, Magnani C, Betta PG, et al. Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol. 1995;48(9): Skov BG, Lauritzen AF, Hirsch FR, Skov T, Nielsen HW. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology. 1994;25(5): Husain AN, Colby T, Ordonez N, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137(5): Allen TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med. 2005;129(11): Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1): Sheffield BS, Hwang HC, Lee AF, et al. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol. 2015;39(7): Righi L, Duregon E, Vatrano S, et al. BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study. J Thorac Oncol. 2016; 11(11): Galateau-Salle F, Churg A, Roggli V, Travis WD; World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization Classification of Tumors of the Pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11(2): Kadota K, Yeh YC, D Angelo SP, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol. 2014;38(8): Choi ER, Lee HY, Jeong JY, et al. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma. Oncotarget. 2016;7(41): Russell PA, Barnett SA, Walkiewicz M, et al. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. J Thorac Oncol. 2013;8(4): Robbins P, Pinder S, de Klerk N, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol. 1995;26(8): Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986; 58(2): Warth A, Cortis J, Fink L, et al. Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch. 2012;461(2): Warth A, Stenzinger A, von Brünneck AC, et al. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J. 2012;40(5): Wang C, Durra HY, Huang Y, Manucha V. Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern. Int J Surg Pathol. 2014;22(2): Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma: an international interobserver study. Mod Pathol. 2012;25(12): Arch Pathol Lab Med Vol 142, June 2018 Reproducibility of Pleural Mesothelioma Subtyping Brcic et al
ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationUpdate: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities. Douglas J. Hartman, MD June 7, 2018
Update: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities Douglas J. Hartman, MD June 7, 2018 Objectives Review Historical Features associated with prognosis Present
More informationMesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016
Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar
More informationMesothelioma Pathobasic. Lukas Bubendorf Pathology
Mesothelioma Pathobasic Lukas Bubendorf Pathology Mechanisms of Asbestos Carcinogenesis in Mesothelioma Asprin High-mobility group protein B1 master switch HMGB1 Initiation/ perpetuation of inflamm. response
More informationWell-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report
Showa Univ J Med Sci 25 1, 67 72, March 2013 Case Report Well-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report Yuri TOMITA
More informationTHE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS
THE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS PULMONARY PATHOLOGY SOCIETY USCAP, BALTIMORE, March 2, 2013 William D. Travis, M.D. Dept of Pathology, Memorial Sloan-Kettering Cancer
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Brčić L., Jakopović M., Brčić I., Klarić V., Milošević M., Šepac A., Samaržija M., Seiwerth S. (2014) Reproducibility of histological subtyping of malignant pleural mesothelioma.
More informationBiopsy Interpretation of Spindle cell proliferations of the Serosa
Biopsy Interpretation of Spindle cell proliferations of the Serosa Richard Attanoos, Cardiff. U.K. Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee)
More informationACCME/Disclosures. Case 4 USCAP Pulmonary Panel Case 4 History
Case 4 USCAP Pulmonary Panel 2016 Andrew Churg, MD Department of Pathology Vancouver General Hospital & University of British Columbia Vancouver, BC achurg@mail.ubc.ca. ACCME/Disclosures The USCAP requires
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationMalignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry
766 J Clin Pathol 2001;54:766 770 Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry Department of Pathology, Victoria Infirmary, Langside
More informationOriginal Articles. Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces
Original Articles Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces Ann E. Walts, MD; Alberto M. Marchevsky, MD Context. Tumor spread
More informationGround Glass Opacities
Ground Glass Opacities A pathologist s perspective Marie-Christine Aubry, M.D. Professor of Pathology Mayo Clinic Objectives Discuss the proposed new pathologic classification of adenocarcinoma with historical
More informationDiffuse malignant pleural mesothelioma (DMPM) is the
ORIGINAL ARTICLE Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid Mesothelioma Kyuichi Kadota,
More informationNon-Small Cell Lung Carcinoma - Myers
Role of Routine Histology and Special Testing in Managing Patients with Non- Small Cell Lung Carcinoma Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of
More informationA Multi-Resolution Deep Learning Framework for Lung Adenocarcinoma Growth Pattern Classification
MIUA2018, 053, v4 (final): Multi-Resolution CNN for Lung Growth Pattern Classification 1 A Multi-Resolution Deep Learning Framework for Lung Adenocarcinoma Growth Pattern Classification Najah Alsubaie
More informationThe pathologic diagnosis of malignant mesothelioma
Review Articles Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group Aliya Noor Husain, MD; Thomas V.
More informationGuidelines for Pathologic Diagnosis of Malignant Mesothelioma. A Consensus Statement from the International Mesothelioma Interest Group
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma A Consensus Statement from the International Mesothelioma Interest Group Aliya N. Husain, MD; Thomas V. Colby, MD; Nelson G. Ordóñez, MD; Thomas
More informationEARLY ONLINE RELEASE
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationAs part of the International Mesothelioma Interest Group
Review Articles Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group Aliya N. Husain, MD; Thomas Colby,
More informationPrudence Anne Russell 1,2, Gavin Michael Wright 3,4
Editorial Page 1 of 7 Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail? Prudence Anne Russell
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationCytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami
Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics Mercè Jordà, University of Miami Mortality Lung cancer is the most frequent cause of cancer incidence and mortality
More informationNeuroendocrine Lung Tumors Myers
Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI myerjeff@umich.edu
More informationExpression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Peiguo G. Chu, M.D., Ph.D., Lawrence M. Weiss, M.D. Department of Pathology, City of Hope National Medical Center,
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More informationLUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS
LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationResearch Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
BioMed Research International, Article ID 64568, 6 pages http://dx.doi.org/.55/24/64568 Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically
More information3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project
Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship
More informationHistological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis
Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type
More informationLung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology
Lung Neoplasia II Resection specimens Pathobasic Lukas Bubendorf Pathology Agenda Preneoplastic lesions Histological subtypes of lung cancer Histological patterns of AC Cells of origin and characteristic
More informationInterobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
Eur Respir J 212; 4: 1221 1227 DOI:.1183/931936.219211 CopyrightßERS 212 Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas Arne Warth*,
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationIASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS
Serban Negoita Dylan Holt Marsha Dunn IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS DEMOGRAPHIC PATTERNS, TRENDS, AND IMPLICATIONS FOR CANCER SURVEILLANCE Outline Relevance of lung adenocarcinoma
More informationProposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma
ORIGINAL ARTICLE LUNG CANCER Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma Wilko Weichert 1,2,3, Claudia Kossakowski 1, Alexander Harms 1, Peter Schirmacher
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationPathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY
Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There
More informationGUT-C 11/30/2017. Debasmita Das, M.D. PGY-1 Danbury Hospital
GUT-C 11/30/2017 Debasmita Das, M.D. PGY-1 Danbury Hospital CLINICAL SUMMARY 8/2017 59 year old female Presented to the ED with 1 month history of general malaise, fever and weight loss PMH: Significant
More informationCell-Adhesion Molecule Expression and the Proliferation of Malignant Mesothelioma: A Post-Mortem Examination
Cell-Adhesion Molecule Expression and the Proliferation of Malignant Mesothelioma: A Post-Mortem Examination KOZO KURIBAYASHI 1*, HIROSHI HIRANO 2*, KEIJI NAKASHO 3, HIDEKI OHYAMA 3, KOJI YAMANEGI 3, CHIHARU
More informationLung neuroendocrine tumors: pathological characteristics
Review Article Lung neuroendocrine tumors: pathological characteristics Luisella Righi 1, Gaia Gatti 1, Marco Volante 1, Mauro Papotti 2 1 Department of Oncology, San Luigi Hospital, Orbassano, Italy;
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationA Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases
Anatomic Pathology / Peritoneal Mesothelioma A Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases Yukio Takeshima, MD, Vishwa
More informationLUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia
LUNG CANCER pathology & molecular biology Izidor Kern University Clinic Golnik, Slovenia 1 Pathology and epidemiology Small biopsy & cytology SCLC 14% NSCC NOS 4% 70% 60% 50% 63% 62% 61% 62% 59% 54% 51%
More informationImmunohistochemical Profile of Lung Tumors in Image Guided Biopsies
Original Article DOI: 10.21276/APALM.1342 Immunohistochemical Profile of Lung Tumors in Image Guided Biopsies T. Pavithra 1 *, A. Dhanalakshmi 1, C. Lalitha 1, K.B. Lavanya 1 and S. Shifa 2 Department
More informationDuring recent decades, many studies have investigated
Differential Diagnosis of Benign and Malignant Mesothelial Proliferations on Pleural Biopsies Philip T. Cagle, MD; Andrew Churg, MD, PhD Context. Although much of the pathology literature focuses on differential
More informationGábor CSERNI. 1. Bács-Kiskun County Teaching Hospital, Kecskemét 2. University of Szeged, Szeged
Lymphocytes infiltrant la tumeur (TIL) sur micro-biopsies et pièces opératoires Quel impact clinique? Quels moyens de mise en évidence? Comment restituer les résultats? TILs - Clinical impact / Evaluation
More informationLung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
More informationDisclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose
Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017
More informationHistologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated With Extrapleural Pneumonectomy
Anatomic Pathology / Malignant Pleural Mesothelioma Histologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated With Extrapleural Pneumonectomy Andrea V. Arrossi, MD, 1 E. Lin,
More informationACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION
POL J PATHOL 2011; 2: 95-100 ACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION OF MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS FERESHTEH ENSANI, FARNAZ NEMATIZADEH, GITI IRVANLOU Department of Cytology, Cancer
More informationNon Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationProblem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships
Differential of Neuroendocrine Carcinoma Alain C. Borczuk,MD Weill Cornell Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control
More information5/1/2009. Squamous Dysplasia/CIS AAH DIPNECH. Adenocarcinoma
Pathological Assessment of Diagnostic Specimens Keith Kerr Department of Pathology Aberdeen University Medical School Aberdeen Royal Infirmary Foresterhill, Aberdeen, Scotland, UK Tumours of the Lung:
More informationProstate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed
More informationPrimary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings
CASE REPORT Primary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings Makoto Nagashima 1, Ayako Moriyama 1, Yasuo
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationTumors of the Lungs and Pleura
5 Tumors of the Lungs and Pleura Saul Suster and Cesar Moran Introduction Carcinoma of the lung is a common malignant tumor. Histological typing of lung tumors has long been a source of controversy in
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More informationValue of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationFollow up of the Guidelines for Cytopathologic Diagnosis of Malignant Mesothelioma
Follow up of the Guidelines for Cytopathologic Diagnosis of Malignant Mesothelioma Assoc. Prof. Katalin Dobra, Senior Lecturer in Molecular Pathology Karolinska University Hospital Stockholm, Sweden Disclosure
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationStandards and datasets for reporting cancers. Dataset for the histopathological reporting of mesothelioma. September 2017
Standards and datasets for reporting cancers Dataset for the histopathological reporting of mesothelioma September 2017 Authors: Professor Andrew G Nicholson, Royal Brompton Hospital and Harefield NHS
More informationSecond predominant subtype predicts outcomes of intermediatemalignant invasive lung adenocarcinoma
European Journal of Cardio-Thoracic Surgery 51 (2017) 218 222 doi:10.1093/ejcts/ezw318 Advance Access publication 6 October 2016 ORIGINAL ARTICLE Cite this article as: Ito M, Miyata Y, Yoshiya T, Tsutani
More informationPOORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?
POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? AGGRESSIVE THYROID CANCERS PAPILLARY CARCINOMA CERTAIN SUBTYPES POORLY DIFFERENTIATED CARCINOMA HIGH GRADE DIFFERENTIATED
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationNeuroendocrine neoplasms of the lung
Neuroendocrine neoplasms of the lung M Papotti, L Righi, & M Volante University of Turin at San Luigi Hospital TORINO NETs OF THE LUNG Menu - Spectrum of NE lung tumors - CARCINOID TUMORS - SCLC /LCNEC
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationMinimally invasive adenocarcinoma. 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS)
Minimally invasive adenocarcinoma 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS) 2b lepidic acinar 2c papillary micropapillary solid 2d cribriform
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationHow to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens
How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens Wenxin Zheng, M.D. Professor of Pathology and Gynecology University of Arizona zhengw@email.arizona.edu http://www.zheng.gynpath.medicine.arizona.edu/index.html
More informationACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI
USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationInsulinoma-associated protein (INSM1) is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens
Insulinoma-associated protein (INSM1) is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens Kartik Viswanathan, M.D., Ph.D New York Presbyterian - Weill
More informationImmunohistochemistry on Fluid Specimens: Technical Considerations
Immunohistochemistry on Fluid Specimens: Technical Considerations Blake Gilks Dept of Pathology University of British Columbia, Vancouver, BC, Canada Disclosures None Learning Objectives At the end of
More informationSystemic Management of Malignant Pleural Mesothelioma
ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY 15.June-19.June 2018 Belgrade, Serbia Systemic Management of Malignant Pleural Mesothelioma Dragana Jovanovic University Hospital
More informationRoot Cause Analysis of Problems in the Frozen Section Diagnosis of In Situ, Minimally Invasive, and Invasive Adenocarcinoma of the Lung
Root Cause Analysis of Problems in the Frozen Section Diagnosis of In Situ, Minimally Invasive, and Invasive Adenocarcinoma of the Lung Ann E. Walts, MD; Alberto M. Marchevsky, MD Context. Frozen sections
More informationMorphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens
ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens C Rose, H Wu Citation C Rose, H Wu.. The Internet Journal of Pathology.
More informationHOW TO GET THE MOST INFORMATION FROM A TUMOR BIOPSY
HOW TO GET THE MOST INFORMATION FROM A TUMOR BIOPSY 7 TH Annual New York Lung Cancer Symposium Saturday, November 10, 2012 William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering
More informationPleomorphic carcinoma of the lung: which CT findings predict poor prognosis?
Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Poster No.: C-1887 Congress: ECR 2015 Type: Scientific Exhibit Authors: A. Fujisaki, T. Aoki, S. Kinoshita, Y. Hayashida, Y.
More informationOriginal Article Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry
Pathology International 2008; 58: 75 83 doi:10.1111/j.1440-1827.2007.02193.x Original Article Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry
More informationSarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
More informationXXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NUEVOS FENOTIPOS DEL CÁNCER DE MAMA: NUEVOS PROBLEMAS PARA EL PATÓLOGO? Tienen actualmente
More informationMinor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis
Ann Surg Oncol (2016) 23:2099 2105 DOI 10.1245/s10434-015-5043-9 ORIGINAL ARTICLE THORACIC ONCOLOGY Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph
More informationHistopathology of NSCLC, IHC markers and ptnm classification
ESMO Preceptorship on Non-Small Cell Lung Cancer November 15 th & 16 th 2017 Singapore Histopathology of NSCLC, IHC markers and ptnm classification Prof Keith M Kerr Department of Pathology, Aberdeen University
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationSELECTED DILEMMAS IN RESPIRATORY CYTOPATHOLOGY (2 CASES)
SELECTED DILEMMAS IN RESPIRATORY CYTOPATHOLOGY (2 CASES) Dr. Mariamma Joseph Professor of Pathology Division Head Cytopathology Department of Pathology and Laboratory Medicine LHSC and Western University
More informationNeoplasms Of The Lung: Based On The Proceedings Of The 57th Annual Anatomic Pathology Slide Seminar Of The American Society Of Clinical Pathologists
Neoplasms Of The Lung: Based On The Proceedings Of The 57th Annual Anatomic Pathology Slide Seminar Of The American Society Of Clinical Pathologists By David H. Dail;Samuel P. Hammar;Darryl Carter If you
More information